18/02/2015 - 21:44 MAUI, HAWAII – There’s been fairly brisk uptake of biosimilar infliximab in Europe, both for new patients and as a possible switch from Remicade.... More » Visit websiteField of Interest: DermatologyCategories: FPN || Video LibraryIMN || Video LibraryONCR || VideoRHEUM || Video LibrarySAN || Video LibraryIMN || FDA & CDCNews Feed: Internal Medicine News - Dermatology